Fulford (India) Ltd
₹0.00▲ +0.00 (+0.00%)
FULFORD·BSE·Healthcare
Market Cap
—
PE Ratio
—
Volume
—
Day High - Low
—
52W High-Low
—
₹0.00▲ +0.00 (+0.00%)
Market Cap—
PE Ratio—
Volume—
Day High - Low—
52W High-Low—
Fulford (India) Ltd (FULFORD): company summary
Fulford (India) Ltd (FULFORD) is an Indian listed company operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
Fulford (India) Ltd (FULFORD) is an Indian listed company operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
- Financial performance
- Revenue has been shrinking at -16.9% a year over three years; profit grew 0.0% a year, ahead of revenue — margins are expanding. Return on equity is 10.6%.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
5.1/10
Weak
Fair Value
Sign in to see
ROE
10.60%
Average
P/E
—
Debt / Equity
—
Industry
Healthcare
Pharmaceuticals & Biotechnology
Overall View
Weak
Price performance
DocStoX take
Supported by risk (7.2) and quality (6.7), but held back by growth (1.5). The latest financials on file are more than 18 months old, so treat the fundamental measures with caution. Scored on 3 of 5 measures.
DocStoX score
Low confidence5.1
/10
Weak
Quality
Solid
ROE 10.6%
Valuation
No data
No valuation multiples
Growth
Flat
Revenue -14.7% 5Y CAGR
Risk
Moderate
Earnings variability 22%
Momentum
No data
No technical indicators
Scored on 3 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
—
52W High / Low
—
Dividend Yield
—
Promoter Holding
—
EPS (TTM)
₹46.36
Book Value
₹294.00
Key highlights
- Profitable in all of the last 5 years
- Healthy net margin (26%)
- Revenue shrinking 15% a year
- Growth is weak (1.5/10)
2 Positives2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals & Biotechnology
Explore Fulford (India) Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Fulford (India) Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Fulford (India) Ltd with peers
Fulford (India) Ltd vs Sun Pharmaceutical Industries LimitedFulford (India) Ltd vs Divi's Laboratories LimitedFulford (India) Ltd vs Torrent Pharmaceuticals LimitedFulford (India) Ltd vs Apollo Hospitals Enterprise LimitedFulford (India) Ltd vs Zydus Lifesciences LimitedFulford (India) Ltd vs Laurus Labs Limited
Related tools & concepts
Value Fulford (India) Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing